134P Safety and efficacy of eribulin and trastuzumab in anti-HER2 therapy pretreated patients with HER2-positive metastatic breast cancer: A Japanese multicenter phase 2 study (SBP-04 study). (20th December 2016) - Shien, T.; Ikeda, M.; Ohtani, S.; Hara, F.; Takahashi, M.; Tuji, H.; Yoshitomi, S.; Matsuoka, K.; Ogasawara, Y.; Taira, N.; Doihara, H.; Ohsumi, S.